B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Capricor Therap (NQ: CAPR )

4.480 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.480
Bid (Size) 3.600 (1)
Ask (Size) 5.040 (2)
Prev. Close 4.480
Today's Range 4.480 - 4.480
52wk Range 2.810 - 6.580
Shares Outstanding 25,255,154
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
Earnings Preview For Capricor Therapeutics
 
Via Benzinga

Performance

YTD
+16.36%
+16.36%
1 Month
+3.94%
+3.94%
3 Month
+30.23%
+30.23%
6 Month
-22.63%
-22.63%
1 Year
-5.49%
-5.49%

More News

Read More
Earnings Scheduled For March 10, 2022
Via Benzinga
Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
Via Benzinga
Capricor Initiates Late-Stage Neuropsychiatric Disorder Study
Via Benzinga
More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
Via Benzinga
7 Undervalued Penny Stocks With Major Upside
Via InvestorPlace
Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Capricor Shares Fall After Topline Results From Mid-Stage COVID-19 Trial
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Capricor Stops Work On Exosome-mRNA Based COVID-19 Vaccine Candidate
Via Benzinga
Capricor Therapeutics: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Capricor Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Capricor Therapeutics, Nippon Shinyaku Ink US Pact For Duchenne Muscular Dystrophy Candidate
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.